The impact of COVID-19 on kidney cancer patients: Survey findings

This video discussion brings together Professor Jamie Landman, urologist from University of California Irvine Medical Center, Dr Monty Pal, medical oncologist from City of Hope Hospital in California, Professor Michael Staehler from Ludwig-Maximilians University, Munich, Germany and Dena Battle, President of KCCure and kidney cancer patient advocate. This Kidney Cancer Today discussion centres around changes […]

read more

Government has issued new guidance for the coronavirus outbreak

The UK Government has released new guidance for supporting disabled people through the coronavirus outbreak and guidance for the public on the mental health and wellbeing aspects of coronavirus: GOV.UK: Supporting disabled people through the coronavirus outbreak GOV.UK: Guidance for the public on the mental health and wellbeing aspects of coronavirus (COVID-19)

read more

First-line immunotherapy combination treatments for metastatic kidney cancer

A meta-analysis of four major clinical trials of immunotherapy combinations for the first-line treatment of metastatic renal cell carcinoma (RCC) was published in the journal Clinical Genitourinary Cancer earlier this month. The analysis compared progression-free survival, overall survival and objective response rate from four major clinical trials: CheckMate 214 (nivolumab/ipilimumab vs sunitinib), Keynote-426 (pembrolizumab/axitinib vs […]

read more

Nivolumab for the treatment of metastatic non-clear cell renal cell carcinoma

Nivolumab alone and in combination with ipilimumab is used for the treatment of patients with metastatic renal cell carcinoma (RCC) in the second- and first-line, respectively. However, since patients with non-clear cell RCC are excluded from clinical trials, there is limited data on the effectiveness of nivolumab for the treatment of these patients. In a […]

read more

COVID-19: Doctors given new guidelines for treating patients in critical care

Amid concerns that the NHS will be overwhelmed by the demand for intensive care beds and ventilators during the coronavirus outbreak, the National Institute for Health and Care Excellence (NICE) have published guidelines to help doctors and nurses prioritise patients during the pandemic. The three new NICE guidelines cover patients needing critical care, kidney dialysis […]

read more

COVID-19 and cancer care at St Barts Hospital, London

Professor Thomas Powles, director of the cancer centre at Barts Cancer Institute in London discusses how oncologists are preparing for and caring for people with genitourinary malignancies in light of the global COVID-19 pandemic. Professor Powles provides a European perspective on the state of the virus today and shares how he and his colleagues have […]

read more

Activity Guide from the Patient Empowerment Network

We hope that you and your families are well and safe during this difficult time. Our thoughts are with each of you as you focus on your own health and safety, and that of your loved ones. We recognise that social distancing will likely be a very lonely and isolating experience for many within the […]

read more

Coronavirus COVID-19 and cancer patients

A recent study from China looked at 1590 people infected with the coronavirus and who had COVID-19. Eighteen (18) of these patient had a history of cancer. People who have cancer are immunosuppressed, and are therefore more susceptible to infection than those without cancer. Immunosuppression is caused by the cancer and its treatment. Patients with […]

read more

Axitinib first-line treatment of papillary renal cell carcinoma

The majority of renal cell carcinomas (RCCs) are a subtype called clear cell RCC. Most drugs have been developed to treat this subtype of RCC, leaving people with other metastatic RCC subtypes with an unmet need for an effective treatment in the first-line. Papillary RCC (pRCC) represents 10-15% of renal cell carcinomas, and is not an insignificant subtype. […]

read more

Advice on coronavirus from One Cancer Voice

Please find below advice on coronavirus for people with cancer in the form of a set of frequently asked questions produced by the One Cancer Voice group of cancer charities. This advice has been updated as of 24 March 2020: Advice on coronavirus for people with cancer 24March2020

read more
Showing 1 to 10 of 749 results
  TOP